Kevin B. Young
Director/Board Member bei Interplast
Profil
Kevin B.
Young currently works at Interplast, as Director.
Mr. Young also formerly worked at Quince Therapeutics, Inc., as Independent Director from 2019 to 2021, Amgen, Inc., as Head-US Inflammation Business from 2001 to 2004, Gilead Sciences, Inc., as Chief Operating Officer, Gilead Sciences, Inc., as Executive Vice President-Commercial Operations from 2004 to 2014, AstraZeneca Pharmaceuticals LP, as Principal, and AstraZeneca, Inc., as Head-US Inflammation Business from 2001 to 2004.
Mr. Young received his graduate degree from The University of Nottingham and undergraduate degree from Liverpool John Moores University.
Aktive Positionen von Kevin B. Young
| Unternehmen | Position | Beginn |
|---|---|---|
Interplast
 Interplast Hospital/Nursing ManagementHealth Services Interplast is a group of individuals founded by Dr. Laub from Stanford University who are concerned with the maldistribution of medicine. Interplast is based in Sunnyvale, CA. The non-profit company provides direct care to people who do not have access to surgery and educate professionals. The group has inspired thousands of international humanitarian trips around the world by many surgeons who are motivated to change lives through plastic and reconstructive surgery. | Director/Board Member | 24.03.2010 |
Ehemalige bekannte Positionen von Kevin B. Young
| Unternehmen | Position | Ende |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director/Board Member | 16.06.2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 04.02.2014 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2004 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | 01.01.2004 |
| GILEAD SCIENCES, INC. | Chief Operating Officer | - |
Ausbildung von Kevin B. Young
| The University of Nottingham | Graduate Degree |
| Liverpool John Moores University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
Interplast
Interplast Hospital/Nursing ManagementHealth Services Interplast is a group of individuals founded by Dr. Laub from Stanford University who are concerned with the maldistribution of medicine. Interplast is based in Sunnyvale, CA. The non-profit company provides direct care to people who do not have access to surgery and educate professionals. The group has inspired thousands of international humanitarian trips around the world by many surgeons who are motivated to change lives through plastic and reconstructive surgery. | Health Services |
